Search Results - "Aleksandrova, E N"

Clinical value of antibodies in inflammatory bowel diseases by Aleksandrova, E N, Novikov, A A, Lukina, G V, Parfenov, A I

“…Inflammatory bowel disease IBD (Crohns disease CD, ulcerative colitis UC) immune-mediated diseases of the digestive tract of unknown etiology. The basis of the…”
Get full text

Diagnosis of IgG4 - related ophthalmic disease in a group of patients with various lesions of the eye and orbits by Vasilyev, V I, Safonova, T N, Socol, E V, Probatova, N A, Kokosadze, N V, Pavlovskaya, A I, Kovrigina, A M, Radenska-Lopovok, S G, Gorodetsky, V R, Rodionova, E B, Palshina, S G, Aleksandrova, E N, Shornikova, N S, Gaiduk, I V

“…To provide demographic, clinical, laboratory, ultrasound, radiological, morphological/ immunomorphological phenotype of IgG4-related ophthalmic diseases, which…”
Get full text

The influence of STAT4 rs7574865 (G/T) polymorphism on the risk of clinical and immunological phenotypes of systemic sclerosis in a Russian patient population: Results of a pilot study by Krylov, M Yu, Ananyeva, L P, Koneva, О А, Starovoytova, M N, Desinova, O V, Ovsyannikova, O B, Aleksandrova, E N, Novikov, A A, Guseva, I A, Konovalova, N V, Varlamov, D A

“…To examine the association of signal transducer and activator transcription 4 (STAT4) rs7574865 G/T polymorphism with a predisposition to systemic sclerosis…”
Get full text

The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis by Avdeeva, A. S., Aleksandrova, E. N., Novikov, A. A., Smirnov, A. V., Cherkasova, M. V., Nasonov, Eugeny L.

“…Objective. To make individualised decisions regarding treatment is one of the most important challenges in clinical practise, and identification of sensitive…”
Get full text

Relationship between matrix metalloproteinase-3 levels and articular destructive changes in early and extended rheumatoid arthritis by Avdeeva, A S, Aleksandrova, E N, Karateev, D E, Panasyuk, E Yu, Smirnov, A V, Cherkasova, M V, Nasonov, E L

“…To estimate a relationship between matrix metalloproteinase-3 (MMP-3) levels and articular radiographic changes in early and extended rheumatoid arthritis…”
Get full text

Systemic autoimmune rheumatic diseases in 2013: problems of laboratory diagnosis by Nasonov, E L, Aleksandrova, E N, Novikov, A A

“…Progress in the laboratory diagnosis of systemic autoimmune rheumatic diseases (SRAD) is caused by the ever increasing clinical introduction of new highly…”
Get full text

IgG4-related salivary gland lesions by V I Vasilyev, E V Sokol, E B Rodionova, S G Palshina, E N Aleksandrova, S G Radenska-lopovok, N A Probatova, N V Kokosadze, A M Kovrigina, T N Safonova, A B Borovskaya, I V Gaiduk

“…Aim. To provide the demographic, clinical, laboratory, radiological, morphological, and immunomorphological characteristics of IgG4-related sialoadenitis…”
Get full text

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs by Kirillova, I G, Novikova, D S, Popkova, T V, Aleksandrova, E N, Novikov, A A, Gorbunova, Yu N, Markelova, E I, Korsakova, Yu O, Glukhova, S I, Volkov, A V, Luchikhina, E L, Demidova, N V, Kasumova, K A, Vladimirov, S A, Kanonirova, M A, Lukina, G L, Karateev, D E, Nasonov, E L

“…To determine N-terminal pro-brain natriuretic peptide (NT-proBNP) levels in patients with early rheumatoid arthritis (RA) before the use of disease-modifying…”
Get full text

Lower Bound of the Length of a Single Fault Diagnostic Test with Respect to Insertions of a Mod-2 Adder by Aleksandrova, N. E., Romanov, D. S.

“…We prove that almost all Boolean functions of n variables implements by arbitrary logic circuits in any functionally complete basis admit a minimal…”
Get full text

Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment by Tsanian, M É, Solov'ev, S K, Torgashina, A V, Aleksandrova, E N, Radenska-Lopovok, S G, Nikolaeva, E V, Khrennikova, Ia B, Nasonov, E L

“…To evaluate the impact of anti-B-cell therapy on the clinical and immunological parameters of systemic lupus erythematosus (SLE) activity, on the time course…”
Get full text

The Length of a Single Fault Detection Test for Constant-Nonpreserving Element Insertions by Aleksandrova, N. E., Romanov, D. S.

“…We prove that every Boolean function other than the constant and the identity function can be realized by an irredundant combinational circuit in the basis {…”
Get full text

Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis by Avdeeva, A S, Aleksandrova, E N, Novikov, A A, Cherkasova, M V, Panasyuk, E Yu, Nasonov, E L

“…To evaluate the impact of tocilizumab (TCZ) therapy on the level of matrix metalloproteinase-3 (MMP-3) 4, 24, and 48 weeks after treatment initiation in…”
Get full text

Tuberculosis situation among the pediatric population of Saratov Region (2015-2019) by Aleksandrova, E. N., Morozova, T. I., Salina, T. Yu

“…Subjects and Methods. Incidence and prevalence of tuberculosis among children and adolescents in Saratov Region were retrospectively analyzed for 2015-2019…”
Get full text

Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome by Reshetniak, T M, Ostriakova, E V, Patrusheva, N L, Patrushev, L I, Aleksandrova, E N, Seredavkina, N V, Volkov, A V, Nasonov, E L

“…To estimate the prevalence of plasminogen activator inhibitor type 1 (PAI-1) gene polymorphism in patients with antiphospholipid syndrome (APS) and its…”
Get full text

Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab by Tsanyan, M E, Torgashina, A V, Aleksandrova, E N, Soloviev, S K, Nasonov, E L

“…To determine the time course of changes in the blood levels of antibodies (Ab) to complement component C1q (a-C1q) in patients with systemic lupus…”
Get full text

Adaptation of Microarray Assay for Serum Amyloid A Analysis in Human Serum by Smoldovskaya, O V, Voloshin, S A, Novikov, A A, Aleksandrova, E N, Feyzkhanova, G U, Rubina, A Yu

“…Serum amyloid A is an inflammatory biomarker whose concentration changes during infectious and inflammatory diseases. SAA's tendency for aggregation and…”
Get more information

Rheumatic diseases: current technologies and perspectives of laboratory diagnosis by Nasonov, E L, Aleksandrova, E N

“…The problems of the laboratory diagnosis of rheumatic diseases (RD), by determining a broad spectrum of biomarkers at the cellular and humoral levels, are…”
Get full text

Evaluation of the efficacy and tolerance of ibandronic acid in patients with osteoarthrosis in the knee joints concurrent with osteoporosis: a pilot study by Alekseeva, L I, Zaitseva, E M, Sharapova, E P, Taskina, E A, Smirnov, A V, Demin, N V, Aleksandrova, E N

“…To evaluate the efficacy and tolerance of ibandronic acid (bonviva) in patients with osteoporosis (OP) concurrent with osteoarthrosis (OA) in the knee joints…”
Get full text

Adaptation of Microarray Assay for Serum Amyloid a Analysis in Human Serum by Smoldovskaya, O. V., Voloshin, S. A., Novikov, A. A., Aleksandrova, E. N., Feyzkhanova, G. U., Rubina, A. Yu

“…Serum amyloid A is an inflammatory biomarker whose concentration changes during infectious and inflammatory diseases. SAA’s tendency for aggregation and…”
Get full text

The magnitude of fatigue and its association with depression, pain, and inflammatory activity in rheumatoid arthritis by Lisitsyna, T A, Veltishchev, D Yu, Gerasimov, A N, Seravina, O F, Kovalevskaya, O B, Zeltyn, A E, Novikov, A A, Aleksandrova, E N, Tallerova, A V, Kovalenko, L P, Durnev, A D, Krasnov, V N, Nasonov, E L

“…To analyze the rate of clinically significant fatigue and to search for its predictors in patients with rheumatoid arthritis (RA). The investigation included…”
Get full text